Tumormarker

Thomas L (1998) Labor und Diagnose. TH-Books Verlagsgesellschaft mbH, Frankfurt/MainGoogle Scholar

Joss R, Cerny T (1990) Sinn und Unsinn von Tumormarkern in der Praxis. Schweiz Med Wschr 120: 693–703PubMedGoogle Scholar

Bates S E, Longo D L (1985) Tumor markers: value and limitations in the management of cancer patients. Cancer Treat Rev 12(3): 163–207PubMedCrossRefGoogle Scholar

Berlin N I (1981) Tumor markers in cancer prevention and detection. Cancer 47[5 Suppl]: 1151–1153PubMedCrossRefGoogle Scholar

Pavlidis N, Kalef-Ezra J, Briassoulis E, Skarlos D, Kosmidis P, Saferiadis K, Bairaktari E, Bafaloukos D, Maravegias A, Theoharis D (1994) Evaluaton of six tumor markers in patients with varcinoma of unknown primary. Med Pediatr Oncol 22(3): 162–167PubMedGoogle Scholar

Sturgeon C (2002) Practice guidelines for tumor marker use in the clinic. Clin Chem 48(8): 1151–1159PubMedGoogle Scholar

http://egtm.web.med.uni-muenchen.de/index2.htmlGoogle Scholar

Sturgeon C (2001) Tumor markers in the laboratory: closing the guideline-practice gap. Clin Biochem 34: 353–359PubMedCrossRefGoogle Scholar

Soletormos G, Schioler V, Nielsen D, Skovsgaard T, Dombernowsky P (1993) Interpretation of results for tumor markers on the basis of analytical imprecision and biological variation. Clin Chem 39(10): 2077–2083PubMedGoogle Scholar

Tuxen M K, Söetormos G, Petersen P H, Schioler V, Dombernowsky P (1999) Assessment of biological variation and analytical imprecision of CA 125, CEA, and TPA in relation to monitoring of ovarian cancer. Gyn Onc 74: 12–22CrossRefGoogle Scholar

Plebani M, Giacomini A, Beghi L, de Paoli M, Roveroni G, Galeotti F, Vorsini A, Fraser C G (1996) Serum tumor markers in monitorino patients: interpretation of results using analytical and biological variation. Anticancer Res 16(4B): 2249–2252PubMedGoogle Scholar

Nap M, Mollgard K, Burtin P, Fleuren G J (1988) Immunohistochemistry of carcino-embryonic antigen in the embryo, fetus and adult. Tumour Biol 9(2–3): 145–153PubMedCrossRefGoogle Scholar

Fukuda I, Yamakado M, Kiyose H (1998) Influence of smoking on serum carcinoembryonic antigen levels in subjects who underwent multiphasic health testing and services. J Med Syst 22(2): 89–93PubMedCrossRefGoogle Scholar

Ohwada A, Takahashi H, Nagaoka I, Iwabuchi K, Mikami O, Kira S (1995) Effect of cigarette smoke on the mRNA and protein expression of carcinoembryonic antigen (CEA), a possible chemoattractant for neutrophils in human bronchioalveolar tissues. Thorax 50(6): 651–657PubMedCrossRefGoogle Scholar

Lurie B B, Loewenstein M S, Zamcheck N (1975) Elevated carcinoembryonic antigen levels and biliary tract obstruction. JAMA 233(4): 326–330PubMedCrossRefGoogle Scholar

Mihmanli M, Dilege E, Demir U, Coskun H, Eroglu T, Uysalol M D (2004) The use of tumor markers as predictors of prognosis in gastric cancer. Hepatogastroenterology 51(59): 1544–1547PubMedGoogle Scholar

Duffy M J (2001) Carcinoembryonic antigen as a marker for colorectal cancer: Is it clinically useful? Clin Chem 47(4): 624–630PubMedGoogle Scholar

Anonymous (1996) Clinical practice guidelines fort he use of tumor markers in breast and colorectal cancer. J Clin Oncol 14(10): 2843–2877Google Scholar

Chalasani N, Horlander J C, Said A, Hoen H, Kopecky K K, Stockberger S M, Manam R, Kwo P Y, Lumeng L (1999) Screening for hepatocellular carcinoma in patients with advanced cirrhosis. Am J Gastroenterol 94: 2988–2993PubMedCrossRefGoogle Scholar

Gambarin-Gelwan M, Wolf D C, Shapiro R, Schwartz M W, Min A D (2000) Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation. Am J Gastroenterol 95(6): 1535–1538PubMedCrossRefGoogle Scholar

Arguedas M R, Chen V K, Eluobeidi M A, Fallon M B (2003) Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost-utility analysis. Am J Gastroenterol 98(3): 679–690PubMedCrossRefGoogle Scholar

Stenman U H (2004) Standardization of assays for human chorionic gonadotropin. Clin Chem 50(5): 798–800PubMedCrossRefGoogle Scholar

Birken S, Berger P, Bidart J M, Weber M, Britow A, Norman R, Sturgeon C, Stenman U H (2003) Preparation and characterization of new WHO reference reagents for human chorionic gonadotropin and metabolites. Clin Chem 49(1): 144–154PubMedCrossRefGoogle Scholar

Huber P R, Bischof P, Kretschmer R, Truschnig M, Halwachs G, Schmidt M (1996) CA 15-3: A multicentre evaluation of automated and manual tests. Eur J Clin Chem Biochem 34: 77–84Google Scholar

Veltri R W, Miller M C, O’Dowd G J, Partin A W (2002) Impact of age on total and complexed prostate-specific antigen cutoffs in a contemporary referral series of men with prostate cancer. Urology 60[Suppl 4A]: 47–52PubMedCrossRefGoogle Scholar

Cheli C D, Levine R, Cambetas D R, Kolker J D, Roberts S B (2002) Age-related reference ranger for complexed prostate-specific antigen and complexed total prostate-specific antigen ratio: results from east texas medical center cancer institute screening campaign. Urology 60[Suppl 4A]: 53–59PubMedCrossRefGoogle Scholar

Ku J H, Kim M E, Lee N K, Park Y H, Ahn J O (2003) Influence of age, anthropometry, and hepatic and renal function on serum prostate-specific antigen levels in healthy middle-age men. Urology 61: 132–136PubMedCrossRefGoogle Scholar

Minardi D, Galosi A B, Dell’Atti L, Hanitzsch H, Mario P, Muzzonigro G (2002) Production of serum-free and total prostate-specific antigen due to prostatic intraepithelial neoplasia. Scand J Urol Nephrol 36: 323–329PubMedCrossRefGoogle Scholar

Tanguay S, Begin L R, Elhilali M M, Behlouli H, Karakiewicz P I, Aprikian A G (2002) Comparative evaluation of total PSA, free/total PSA, and complexed PSA in prostate cancer detection. Urology 59: 261–265PubMedCrossRefGoogle Scholar

Guadagni F, Roselli M, Amato T, Cosimelli M, Perri P, Casale V, Carlini M, Santoro E, Cavaliere R, Greiner J W (1992) CA 72-4 measurement of tumor associated glycoprotein 72 (TAG-72) as a serum marker in the magagement of gastric carcinoma. Cancer Res 52(5): 1222–1227PubMedGoogle Scholar

Lai I R, Lee W J, Huang M T, Lin H H (2002) Comparison of serum CA72-4, CEA, TPA, CA 19-9 and CA125 levels in gastric cancer patients and correlation with recurrence. Hepatogastroenterology 49(46): 1157–1160PubMedGoogle Scholar

Filella X, Molina R, Jo J, Bedini J L, Joseph J, Ballesta A M (1992) Tumor associated glycoprotein-72 (TAG-72) levels in patients with non-malignant and malignant disease. Bull Cancer 79(3): 271–277PubMedGoogle Scholar